Alphalytik Pharmaservice

Alphalytik Pharmaservice

Berlin, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2M

Overview

Alphalytik Pharmaservice is a specialized service provider offering GMP laboratory analytics and consulting to the pharmaceutical industry, ensuring product integrity and regulatory compliance throughout a drug's lifecycle. Founded in 1995, the company has processed over 3.5 million tablets and completed thousands of projects, building a reputation for precision and reliability. Its mission is to provide clients with maximum safety and compliance through a combination of expert analysis, tailored consulting, and validation services. The company's strategic direction focuses on leveraging deep regulatory expertise and efficient processes to minimize client risk and accelerate product development.

Drug Delivery

Technology Platform

A service platform centered on GMP-compliant pharmaceutical analytics, method validation, and regulatory consulting, utilizing a comprehensive suite of analytical techniques and deep expertise in global quality standards to support drug development and manufacturing.

Funding History

1
Total raised:$2M
Seed$2M

Opportunities

Growth is driven by increasing pharmaceutical outsourcing, the complexity of new drug modalities (like biologics), and stringent global regulations requiring specialized compliance expertise.
The company can expand by adding new analytical capabilities, targeting emerging biotech firms, or offering more integrated program management services.

Risk Factors

Key risks include intense competition from larger global CROs, reliance on a stable regulatory environment, the need for continuous capital investment in laboratory technology, and challenges in attracting and retaining specialized scientific and regulatory talent.

Competitive Landscape

Competes with large global CROs (e.g., LabCorp, IQVIA) and niche analytical labs. Differentiation is based on deep, specialized expertise in European GMP standards, a focus on pharmaceutical analytics (not broad clinical research), and likely greater agility and personalized service as a mid-sized, established German provider.